infections and tuberculosis

The so-called biological agents are specific modulators of white blood cells that effectively control inflammation and include abatacept, which reduces the number of T cells, 17 rituximab, which reduces the number of B18 cells and TNF inhibitors.

Which block TNF, a protein involved in the production of inflammation, and include: adalimumab, etanercept and infliximab. Multiple adverse events have been attributed to them Flekosteel, especially severe opportunistic infections and tuberculosis. The cost of these agents is much higher than conventional therapies.